These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32249656)

  • 1. Therapeutic outcome of diphencyprone and its correlation with serum cytokine profile in alopecia areata.
    Manimaran RP; Ramassamy S; Rajappa M; Chandrashekar L
    J Dermatolog Treat; 2022 Feb; 33(1):324-328. PubMed ID: 32249656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum level of IL-4 predicts response to topical immunotherapy with diphenylcyclopropenone in alopecia areata.
    Gong Y; Zhao Y; Zhang X; Qi S; Li S; Ye Y; Yang J; Caulloo S; McElwee KJ; Zhang X
    Exp Dermatol; 2020 Mar; 29(3):231-238. PubMed ID: 30047620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diphenylcyclopropenone plays an effective therapeutic role by up-regulating the TSLP/OX40L/IL-13 pathway in severe alopecia areata.
    Gong Y; Luo L; Li L; He X; Lu W; Sha X; Mao Y
    Exp Dermatol; 2021 Feb; 30(2):278-283. PubMed ID: 33325128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DPCP for the treatment of alopecia areata.
    Bolduc C; Shapiro J
    Skin Therapy Lett; 2000; 5(5):3-4. PubMed ID: 10854342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hair Regrowth Outcomes of Contact Immunotherapy for Patients With Alopecia Areata: A Systematic Review and Meta-analysis.
    Lee S; Kim BJ; Lee YB; Lee WS
    JAMA Dermatol; 2018 Oct; 154(10):1145-1151. PubMed ID: 30073292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of diphenylcyclopropenone alone or in combination with anthralin in the treatment of chronic extensive alopecia areata: a retrospective case series.
    Durdu M; Özcan D; Baba M; Seçkin D
    J Am Acad Dermatol; 2015 Apr; 72(4):640-50. PubMed ID: 25653027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alopecia areata in children: treatment with diphencyprone.
    Schuttelaar ML; Hamstra JJ; Plinck EP; Peereboom-Wynia JD; Vuzevski VD; Mulder PG; Oranje AP
    Br J Dermatol; 1996 Oct; 135(4):581-5. PubMed ID: 8915150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diphencyprone in the treatment of alopecia areata.
    Happle R; Hausen BM; Wiesner-Menzel L
    Acta Derm Venereol; 1983; 63(1):49-52. PubMed ID: 6191489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diphenylcyclopropenone (diphencyprone, DPCP) in the treatment of chronic severe alopecia areata (AA).
    Galadari I; Rubaie S; Alkaabi J; Galadari H
    Eur Ann Allergy Clin Immunol; 2003 Dec; 35(10):397-401. PubMed ID: 14768526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone (DPCP): experience in an Iranian population.
    Aghaei S
    BMC Dermatol; 2005 May; 5():6. PubMed ID: 15918897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized trial of diphenylcyclopropenone (DPCP) combined with anthralin versus DPCP alone for treating moderate to severe alopecia areata.
    Ghandi N; Daneshmand R; Hatami P; Abedini R; Nasimi M; Aryanian Z; Vance TM
    Int Immunopharmacol; 2021 Oct; 99():107971. PubMed ID: 34298402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diphencyprone in the treatment of long-standing alopecia areata.
    Hull SM; Norris JF
    Br J Dermatol; 1988 Sep; 119(3):367-74. PubMed ID: 3052565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imiquimod-enhanced immunotherapy with diphencyprone for patients with alopecia areata.
    Díaz-Guimaraens B; Saceda-Corralo D; Hermosa-Gelbard Á; Moreno-Arrones ÓM; Dominguez-Santas M; Suarez-Valle A; Vañó-Galván S
    Dermatol Ther; 2022 Jul; 35(7):e15516. PubMed ID: 35421278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of anthralin in combination with diphenylcyclopropenone in the treatment of alopecia areata: a retrospective case series.
    Nasimi M; Ghandi N; Abedini R; Mirshamsi A; Shakoei S; Seirafi H
    Arch Dermatol Res; 2019 Oct; 311(8):607-613. PubMed ID: 31165933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The profile of cytokines (IL-2, IFN-γ, IL-4, IL-10, IL-17A, and IL-23) in active alopecia areata.
    Gautam RK; Singh Y; Gupta A; Arora P; Khurana A; Chitkara A
    J Cosmet Dermatol; 2020 Jan; 19(1):234-240. PubMed ID: 31087753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alopecia areata: topical immunotherapy treatment with diphencyprone.
    Avgerinou G; Gregoriou S; Rigopoulos D; Stratigos A; Kalogeromitros D; Katsambas A
    J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):320-3. PubMed ID: 18005118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoration of hair growth with topical diphencyprone in mouse and rat models of alopecia areata.
    Tang L; Lui H; Sundberg JP; Bissonnette R; McLean DI; Shapiro J
    J Am Acad Dermatol; 2003 Dec; 49(6):1013-9. PubMed ID: 14639378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of hair growth in alopecia totalis with diphencyprone sensitization.
    Monk B
    Clin Exp Dermatol; 1989 Mar; 14(2):154-7. PubMed ID: 2598490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of diphencyprone on expression of Bcl-2 protein in patients with alopecia areata.
    Pazoki-Toroudi H; Ajami M; Babakoohi S; Khaki L; Habibey R; Akhiani M; Seirafi H; Firooz A
    Immunopharmacol Immunotoxicol; 2010 Sep; 32(3):422-5. PubMed ID: 20095801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical diphencyprone for alopecia areata: evaluation of 48 cases after 30 months' follow-up.
    Gordon PM; Aldrige RD; McVittie E; Hunter JA
    Br J Dermatol; 1996 May; 134(5):869-71. PubMed ID: 8736327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.